These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37348855)

  • 1. Sample size for partially nested designs and other nested or crossed designs with a continuous outcome when adjusted for baseline.
    Teerenstra S; Kasza J; Leontjevas R; Forbes AB
    Stat Med; 2023 Aug; 42(19):3568-3592. PubMed ID: 37348855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriate statistical methods for analysing partially nested randomised controlled trials with continuous outcomes: a simulation study.
    Candlish J; Teare MD; Dimairo M; Flight L; Mandefield L; Walters SJ
    BMC Med Res Methodol; 2018 Oct; 18(1):105. PubMed ID: 30314463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size considerations for assessing treatment effect heterogeneity in randomized trials with heterogeneous intracluster correlations and variances.
    Tong G; Taljaard M; Li F
    Stat Med; 2023 Aug; 42(19):3392-3412. PubMed ID: 37316956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of optimal designs under a given budget in cluster randomized trials with a binary outcome.
    Liu J; Liu L; James AS; Colditz GA
    Stat Methods Med Res; 2023 Jul; 32(7):1420-1441. PubMed ID: 37284817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of complex, partially nested clustering in a three-arm individually randomized group treatment trial: A case study with the wHOPE trial.
    Tong G; Seal KH; Becker WC; Li F; Dziura JD; Peduzzi PN; Esserman DA
    Clin Trials; 2022 Feb; 19(1):3-13. PubMed ID: 34693748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The optimal design of stepped wedge trials with equal allocation to sequences and a comparison to other trial designs.
    Thompson JA; Fielding K; Hargreaves J; Copas A
    Clin Trials; 2017 Dec; 14(6):639-647. PubMed ID: 28797179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Power and sample size calculations for cluster randomized trials with binary outcomes when intracluster correlation coefficients vary by treatment arm.
    Kennedy-Shaffer L; Hughes MD
    Clin Trials; 2022 Feb; 19(1):42-51. PubMed ID: 34879711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-efficient designs for three-arm trials with treatment delivered by health professionals: Sample sizes for a combination of nested and crossed designs.
    Moerbeek M
    Clin Trials; 2018 Apr; 15(2):169-177. PubMed ID: 29316807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal design of cluster randomized trials allowing unequal allocation of clusters and unequal cluster size between arms.
    Copas AJ; Hooper R
    Stat Med; 2021 Nov; 40(25):5474-5486. PubMed ID: 34312902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and analysis of a 2-year parallel follow-up of repeated ivermectin mass drug administrations for control of malaria: Small sample considerations for cluster-randomized trials with count data.
    Jackson CL; Colborn K; Gao D; Rao S; Slater HC; Parikh S; Foy BD; Kittelson J
    Clin Trials; 2021 Oct; 18(5):582-593. PubMed ID: 34218684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample size calculation for treatment effects in randomized trials with fixed cluster sizes and heterogeneous intraclass correlations and variances.
    Candel MJ; van Breukelen GJ
    Stat Methods Med Res; 2015 Oct; 24(5):557-73. PubMed ID: 25519890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample size calculation for stepped wedge and other longitudinal cluster randomised trials.
    Hooper R; Teerenstra S; de Hoop E; Eldridge S
    Stat Med; 2016 Nov; 35(26):4718-4728. PubMed ID: 27350420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing multicenter individually randomized group treatment trials.
    Tong G; Tong J; Li F
    Biom J; 2024 Jan; 66(1):e2200307. PubMed ID: 37768850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size calculations for 3-level cluster randomized trials.
    Teerenstra S; Moerbeek M; van Achterberg T; Pelzer BJ; Borm GF
    Clin Trials; 2008; 5(5):486-95. PubMed ID: 18827041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient design of cluster randomized trials with treatment-dependent costs and treatment-dependent unknown variances.
    van Breukelen GJP; Candel MJJM
    Stat Med; 2018 Sep; 37(21):3027-3046. PubMed ID: 29888393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal designs in three-level cluster randomized trials with a binary outcome.
    Liu J; Liu L; Colditz GA
    Stat Med; 2019 Sep; 38(20):3733-3746. PubMed ID: 31162709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient treatment allocation in two-way nested designs.
    Lemme F; van Breukelen GJ; Berger MP
    Stat Methods Med Res; 2015 Oct; 24(5):494-512. PubMed ID: 24030312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and analysis of trials with a partially nested design and a binary outcome measure.
    Roberts C; Batistatou E; Roberts SA
    Stat Med; 2016 May; 35(10):1616-36. PubMed ID: 26670388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing three-level cluster randomized trials to assess treatment effect heterogeneity.
    Li F; Chen X; Tian Z; Esserman D; Heagerty PJ; Wang R
    Biostatistics; 2023 Oct; 24(4):833-849. PubMed ID: 35861621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.